Literature DB >> 1676603

Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression.

C R Knight1, R C Rees, M Griffin.   

Abstract

The relationship between transglutaminase activity, apoptosis and the propensity of a tumour to metastasise, was investigated in a series of metastatic variants of an HSV-2 induced hamster fibrosarcoma and two metastatic variants of the B16 mouse melanoma. The data suggest an inverse relationship between metastatic potential and cytosolic transglutaminase activity. A direct relationship was found between measured cytosolic activity and the levels of the endogenous product of transglutaminase, the protein crosslink epsilon(gamma-glutamyl)lysine. Increasing metastatic potential and decreasing cytosolic transglutaminase activity was accompanied by a corresponding decrease in the number of detergent-insoluble apoptotic envelopes isolated from variant cell lines. These apoptotic envelopes were found to be highly crosslinked structures, containing more than 85% of the cells content of epsilon(gamma-glutamyl)lysine. These data are in keeping with the idea that a major role for the cytosolic transglutaminase is in the formation of the highly crosslinked apoptotic envelope during programmed cell death and that perturbation of this function may be an important determinant in the development of the metastatic phenotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1676603     DOI: 10.1016/0925-4439(91)90067-j

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

Review 1.  Regulation of apoptosis in immune cells.

Authors:  J D Mountz; T Zhou; J Wu; W Wang; X Su; J Cheng
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

Review 2.  The pathophysiology and management of spine metastasis from lung cancer.

Authors:  J S Greenberger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Enhanced apoptosis in transformed human lung fibroblasts after exposure to sodium butyrate.

Authors:  G L Thomas; A Henley; T C Rowland; A Sahai; M Griffin; P J Birckbichler
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-09       Impact factor: 2.416

4.  The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.

Authors:  T S Johnson; M Griffin; G L Thomas; J Skill; A Cox; B Yang; B Nicholas; P J Birckbichler; C Muchaneta-Kubara; A Meguid El Nahas
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

5.  Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas.

Authors:  T S Johnson; C I Scholfield; J Parry; M Griffin
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Factor XIIIa-positive dendrocytes and proliferative activity of cutaneous cancers.

Authors:  C Piérard-Franchimont; J E Arrese; A F Nikkels; W al-Saleh; P Delvenne; G E Piérard
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

7.  Interleukin-2-activated human effector lymphocytes mediate cytotoxicity by inducing apoptosis in human leukaemia and solid tumour target cells.

Authors:  C R Knight; R C Rees; A Platts; T Johnson; M Griffin
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

Review 8.  Transglutaminase is a tumor cell and cancer stem cell survival factor.

Authors:  Richard L Eckert; Matthew L Fisher; Dan Grun; Gautam Adhikary; Wen Xu; Candace Kerr
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

9.  Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells.

Authors:  G Melino; M Annicchiarico-Petruzzelli; L Piredda; E Candi; V Gentile; P J Davies; M Piacentini
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

Review 10.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.